#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=4. Molecular Mechanisms of Trichothecene Resistance
1-1	0-2	4.	_	_	_	_
1-2	3-12	Molecular	abstract[1]	new[1]	_	_
1-3	13-23	Mechanisms	abstract[1]	new[1]	_	_
1-4	24-26	of	abstract[1]	new[1]	_	_
1-5	27-40	Trichothecene	abstract[1]|place|organization[3]	new[1]|new|new[3]	coref|coref|coref|coref	3-1|4-1[6_3]|3-1|4-1[6_3]
1-6	41-51	Resistance	abstract[1]|organization[3]	new[1]|new[3]	_	_

#Text=4.1 .
2-1	52-55	4.1	abstract	new	_	_
2-2	56-57	.	_	_	_	_

#Text=Trichothecene
3-1	58-71	Trichothecene	place	giv	_	_

#Text=Resistance at the Ribosome
4-1	72-82	Resistance	organization[6]	giv[6]	_	_
4-2	83-85	at	organization[6]	giv[6]	_	_
4-3	86-89	the	organization[6]|place[7]	giv[6]|new[7]	coref	5-9[9_7]
4-4	90-98	Ribosome	organization[6]|place[7]	giv[6]|new[7]	_	_

#Text=Owing to the ubiquitous and essential activities of the ribosome , its structure is highly conserved within phylogenetic domains , making it a reliable target for pathogens .
5-1	99-104	Owing	_	_	_	_
5-2	105-107	to	_	_	_	_
5-3	108-111	the	abstract[8]	new[8]	_	_
5-4	112-122	ubiquitous	abstract[8]	new[8]	_	_
5-5	123-126	and	abstract[8]	new[8]	_	_
5-6	127-136	essential	abstract[8]	new[8]	_	_
5-7	137-147	activities	abstract[8]	new[8]	_	_
5-8	148-150	of	abstract[8]	new[8]	_	_
5-9	151-154	the	abstract[8]|object[9]	new[8]|giv[9]	ana	5-12[0_9]
5-10	155-163	ribosome	abstract[8]|object[9]	new[8]|giv[9]	_	_
5-11	164-165	,	_	_	_	_
5-12	166-169	its	object|abstract[11]	giv|new[11]	ana|ana	5-22|5-22
5-13	170-179	structure	abstract[11]	new[11]	_	_
5-14	180-182	is	_	_	_	_
5-15	183-189	highly	_	_	_	_
5-16	190-199	conserved	_	_	_	_
5-17	200-206	within	_	_	_	_
5-18	207-219	phylogenetic	abstract[12]	new[12]	_	_
5-19	220-227	domains	abstract[12]	new[12]	_	_
5-20	228-229	,	_	_	_	_
5-21	230-236	making	_	_	_	_
5-22	237-239	it	object	giv	coref	6-1[15_0]
5-23	240-241	a	_	_	_	_
5-24	242-250	reliable	_	_	_	_
5-25	251-257	target	_	_	_	_
5-26	258-261	for	_	_	_	_
5-27	262-271	pathogens	animal	new	_	_
5-28	272-273	.	_	_	_	_

#Text=The ribosome can resist the effect of trichothecenes if a point mutation occurs at the tryptophan ( W ) residue within the highly conserved W-finger of Ribosomal Protein L3 ( RPL3 ) .
6-1	274-277	The	object[15]	giv[15]	coref	19-15[159_15]
6-2	278-286	ribosome	object[15]	giv[15]	_	_
6-3	287-290	can	_	_	_	_
6-4	291-297	resist	_	_	_	_
6-5	298-301	the	abstract[16]	new[16]	coref	13-20[90_16]
6-6	302-308	effect	abstract[16]	new[16]	_	_
6-7	309-311	of	abstract[16]	new[16]	_	_
6-8	312-326	trichothecenes	abstract[16]|substance	new[16]|new	_	_
6-9	327-329	if	_	_	_	_
6-10	330-331	a	abstract[19]	new[19]	coref	10-16[61_19]
6-11	332-337	point	abstract|abstract[19]	new|new[19]	_	_
6-12	338-346	mutation	abstract[19]	new[19]	_	_
6-13	347-353	occurs	_	_	_	_
6-14	354-356	at	_	_	_	_
6-15	357-360	the	substance[20]	new[20]	coref	9-6[50_20]
6-16	361-371	tryptophan	substance[20]	new[20]	_	_
6-17	372-373	(	_	_	_	_
6-18	374-375	W	person	new	_	_
6-19	376-377	)	_	_	_	_
6-20	378-385	residue	abstract[22]	new[22]	_	_
6-21	386-392	within	abstract[22]	new[22]	_	_
6-22	393-396	the	abstract[22]|abstract[23]	new[22]|new[23]	coref	8-2[0_23]
6-23	397-403	highly	abstract[22]|abstract[23]	new[22]|new[23]	_	_
6-24	404-413	conserved	abstract[22]|abstract[23]	new[22]|new[23]	_	_
6-25	414-422	W-finger	abstract[22]|abstract[23]	new[22]|new[23]	_	_
6-26	423-425	of	abstract[22]|abstract[23]	new[22]|new[23]	_	_
6-27	426-435	Ribosomal	abstract[22]|abstract[23]|abstract[25]	new[22]|new[23]|new[25]	appos	6-31[0_25]
6-28	436-443	Protein	abstract[22]|abstract[23]|substance|abstract[25]	new[22]|new[23]|new|new[25]	coref	8-10[40_0]
6-29	444-446	L3	abstract[22]|abstract[23]|abstract[25]	new[22]|new[23]|new[25]	_	_
6-30	447-448	(	_	_	_	_
6-31	449-453	RPL3	abstract	giv	coref	8-11
6-32	454-455	)	_	_	_	_
6-33	456-457	.	_	_	_	_

#Text=Mutations at this site also confer resistance to other “ antibiotics ” [ e. g. , anisomycin , 211 ] , that bind the A-site of the peptidyl transferase center .
7-1	458-467	Mutations	abstract[27]	new[27]	coref	11-6[67_27]
7-2	468-470	at	abstract[27]	new[27]	_	_
7-3	471-475	this	abstract[27]|abstract[28]	new[27]|new[28]	coref	8-6[38_28]
7-4	476-480	site	abstract[27]|abstract[28]	new[27]|new[28]	_	_
7-5	481-485	also	_	_	_	_
7-6	486-492	confer	_	_	_	_
7-7	493-503	resistance	abstract	new	coref	11-12
7-8	504-506	to	_	_	_	_
7-9	507-512	other	substance[30]	new[30]	_	_
7-10	513-514	“	substance[30]	new[30]	_	_
7-11	515-526	antibiotics	substance[30]	new[30]	_	_
7-12	527-528	”	substance[30]	new[30]	_	_
7-13	529-530	[	_	_	_	_
7-14	531-533	e.	_	_	_	_
7-15	534-536	g.	_	_	_	_
7-16	537-538	,	_	_	_	_
7-17	539-549	anisomycin	substance[31]	new[31]	_	_
7-18	550-551	,	substance[31]	new[31]	_	_
7-19	552-555	211	substance[31]	new[31]	_	_
7-20	556-557	]	_	_	_	_
7-21	558-559	,	_	_	_	_
7-22	560-564	that	_	_	_	_
7-23	565-569	bind	_	_	_	_
7-24	570-573	the	place[32]	new[32]	_	_
7-25	574-580	A-site	place[32]	new[32]	_	_
7-26	581-583	of	place[32]	new[32]	_	_
7-27	584-587	the	place[32]|object[35]	new[32]|new[35]	_	_
7-28	588-596	peptidyl	place[32]|time|object[35]	new[32]|new|new[35]	coref	8-17
7-29	597-608	transferase	place[32]|object|object[35]	new[32]|new|new[35]	_	_
7-30	609-615	center	place[32]|object[35]	new[32]|new[35]	_	_
7-31	616-617	.	_	_	_	_

#Text=The W-finger projects directly into this site , and the RPL3 protein coordinates aa-tRNA accommodation , peptidyl transfer and translocation steps during protein translation .
8-1	618-621	The	abstract[37]	new[37]	_	_
8-2	622-630	W-finger	abstract|abstract[37]	giv|new[37]	coref	11-6
8-3	631-639	projects	abstract[37]	new[37]	_	_
8-4	640-648	directly	abstract[37]	new[37]	_	_
8-5	649-653	into	abstract[37]	new[37]	_	_
8-6	654-658	this	abstract[37]|place[38]	new[37]|giv[38]	_	_
8-7	659-663	site	abstract[37]|place[38]	new[37]|giv[38]	_	_
8-8	664-665	,	_	_	_	_
8-9	666-669	and	_	_	_	_
8-10	670-673	the	substance[40]	giv[40]	coref	8-23[0_40]
8-11	674-678	RPL3	abstract|substance[40]	giv|giv[40]	coref	12-4[81_0]
8-12	679-686	protein	substance[40]	giv[40]	_	_
8-13	687-698	coordinates	_	_	_	_
8-14	699-706	aa-tRNA	place|event[42]	new|new[42]	coref|ana|coref|ana	10-12|10-21[0_42]|10-12|10-21[0_42]
8-15	707-720	accommodation	event[42]	new[42]	_	_
8-16	721-722	,	_	_	_	_
8-17	723-731	peptidyl	abstract|abstract[44]	giv|new[44]	_	_
8-18	732-740	transfer	abstract[44]	new[44]	_	_
8-19	741-744	and	_	_	_	_
8-20	745-758	translocation	place|abstract[46]	new|new[46]	_	_
8-21	759-764	steps	abstract[46]	new[46]	_	_
8-22	765-771	during	abstract[46]	new[46]	_	_
8-23	772-779	protein	abstract[46]|substance|abstract[48]	new[46]|giv|new[48]	coref|coref|coref|coref	10-26[0_48]|18-18[144_0]|10-26[0_48]|18-18[144_0]
8-24	780-791	translation	abstract[46]|abstract[48]	new[46]|new[48]	_	_
8-25	792-793	.	_	_	_	_

#Text=Only a few substitutions of the tryptophan in this position are viable , including substitutions with other aromatic residues , or with cysteine or arginine .
9-1	794-798	Only	_	_	_	_
9-2	799-800	a	abstract[49]	new[49]	_	_
9-3	801-804	few	abstract[49]	new[49]	_	_
9-4	805-818	substitutions	abstract[49]	new[49]	_	_
9-5	819-821	of	abstract[49]	new[49]	_	_
9-6	822-825	the	abstract[49]|substance[50]	new[49]|giv[50]	_	_
9-7	826-836	tryptophan	abstract[49]|substance[50]	new[49]|giv[50]	_	_
9-8	837-839	in	abstract[49]|substance[50]	new[49]|giv[50]	_	_
9-9	840-844	this	abstract[49]|substance[50]|abstract[51]	new[49]|giv[50]|new[51]	_	_
9-10	845-853	position	abstract[49]|substance[50]|abstract[51]	new[49]|giv[50]|new[51]	_	_
9-11	854-857	are	_	_	_	_
9-12	858-864	viable	_	_	_	_
9-13	865-866	,	_	_	_	_
9-14	867-876	including	_	_	_	_
9-15	877-890	substitutions	abstract[52]	new[52]	_	_
9-16	891-895	with	abstract[52]	new[52]	_	_
9-17	896-901	other	abstract[52]|substance[53]	new[52]|new[53]	_	_
9-18	902-910	aromatic	abstract[52]|substance[53]	new[52]|new[53]	_	_
9-19	911-919	residues	abstract[52]|substance[53]	new[52]|new[53]	_	_
9-20	920-921	,	_	_	_	_
9-21	922-924	or	_	_	_	_
9-22	925-929	with	_	_	_	_
9-23	930-938	cysteine	substance	new	_	_
9-24	939-941	or	_	_	_	_
9-25	942-950	arginine	substance	new	_	_
9-26	951-952	.	_	_	_	_

#Text=Studies in yeast show that the W255C substitution increases affinity to aa-tRNA , and while this mutation is non-lethal , it does result in reduced translation efficiency .
10-1	953-960	Studies	abstract[56]	new[56]	_	_
10-2	961-963	in	abstract[56]	new[56]	_	_
10-3	964-969	yeast	abstract[56]|substance	new[56]|new	coref	14-27
10-4	970-974	show	_	_	_	_
10-5	975-979	that	_	_	_	_
10-6	980-983	the	abstract[58]	new[58]	_	_
10-7	984-989	W255C	abstract[58]	new[58]	_	_
10-8	990-1002	substitution	abstract[58]	new[58]	_	_
10-9	1003-1012	increases	_	_	_	_
10-10	1013-1021	affinity	abstract[59]	new[59]	_	_
10-11	1022-1024	to	abstract[59]	new[59]	_	_
10-12	1025-1032	aa-tRNA	abstract[59]|substance	new[59]|giv	_	_
10-13	1033-1034	,	_	_	_	_
10-14	1035-1038	and	_	_	_	_
10-15	1039-1044	while	_	_	_	_
10-16	1045-1049	this	abstract[61]	giv[61]	_	_
10-17	1050-1058	mutation	abstract[61]	giv[61]	_	_
10-18	1059-1061	is	_	_	_	_
10-19	1062-1072	non-lethal	_	_	_	_
10-20	1073-1074	,	_	_	_	_
10-21	1075-1077	it	event	giv	_	_
10-22	1078-1082	does	_	_	_	_
10-23	1083-1089	result	_	_	_	_
10-24	1090-1092	in	_	_	_	_
10-25	1093-1100	reduced	abstract[64]	new[64]	ana	11-1[0_64]
10-26	1101-1112	translation	abstract|abstract[64]	giv|new[64]	coref	11-20
10-27	1113-1123	efficiency	abstract[64]	new[64]	_	_
10-28	1124-1125	.	_	_	_	_

#Text=It is not known whether W-finger mutations occur as a natural resistance mechanism in plants , although in vitro translation assays demonstrated that ribosomes isolated from the FHB-resistant cultivar , Frontana , exhibit a higher tolerance to DON than those isolated from the susceptible cultivar Cassavant .
11-1	1126-1128	It	abstract	giv	_	_
11-2	1129-1131	is	_	_	_	_
11-3	1132-1135	not	_	_	_	_
11-4	1136-1141	known	_	_	_	_
11-5	1142-1149	whether	_	_	_	_
11-6	1150-1158	W-finger	abstract|abstract[67]	giv|giv[67]	coref|coref	13-13[88_0]|13-13[88_0]
11-7	1159-1168	mutations	abstract[67]	giv[67]	_	_
11-8	1169-1174	occur	_	_	_	_
11-9	1175-1177	as	_	_	_	_
11-10	1178-1179	a	_	_	_	_
11-11	1180-1187	natural	_	_	_	_
11-12	1188-1198	resistance	abstract	giv	coref	15-24[110_0]
11-13	1199-1208	mechanism	_	_	_	_
11-14	1209-1211	in	_	_	_	_
11-15	1212-1218	plants	plant	new	coref	14-3[94_0]
11-16	1219-1220	,	_	_	_	_
11-17	1221-1229	although	_	_	_	_
11-18	1230-1232	in	_	_	_	_
11-19	1233-1238	vitro	place[71]	new[71]	_	_
11-20	1239-1250	translation	abstract|place[71]	giv|new[71]	coref	22-54
11-21	1251-1257	assays	place[71]	new[71]	_	_
11-22	1258-1270	demonstrated	_	_	_	_
11-23	1271-1275	that	_	_	_	_
11-24	1276-1285	ribosomes	object	new	coref	22-43[200_0]
11-25	1286-1294	isolated	_	_	_	_
11-26	1295-1299	from	_	_	_	_
11-27	1300-1303	the	plant[74]	new[74]	coref	11-44[78_74]
11-28	1304-1317	FHB-resistant	person|plant[74]	new|new[74]	_	_
11-29	1318-1326	cultivar	plant[74]	new[74]	_	_
11-30	1327-1328	,	_	_	_	_
11-31	1329-1337	Frontana	object	new	_	_
11-32	1338-1339	,	_	_	_	_
11-33	1340-1347	exhibit	_	_	_	_
11-34	1348-1349	a	abstract[76]	new[76]	coref	15-15[106_76]
11-35	1350-1356	higher	abstract[76]	new[76]	_	_
11-36	1357-1366	tolerance	abstract[76]	new[76]	_	_
11-37	1367-1369	to	abstract[76]	new[76]	_	_
11-38	1370-1373	DON	abstract[76]|place[77]	new[76]|new[77]	coref	13-31[0_77]
11-39	1374-1378	than	abstract[76]|place[77]	new[76]|new[77]	_	_
11-40	1379-1384	those	abstract[76]|place[77]	new[76]|new[77]	_	_
11-41	1385-1393	isolated	_	_	_	_
11-42	1394-1398	from	_	_	_	_
11-43	1399-1402	the	object[79]	new[79]	_	_
11-44	1403-1414	susceptible	plant[78]|object[79]	giv[78]|new[79]	_	_
11-45	1415-1423	cultivar	plant[78]|object[79]	giv[78]|new[79]	_	_
11-46	1424-1433	Cassavant	object[79]	new[79]	_	_
11-47	1434-1435	.	_	_	_	_

#Text=Transgenic expression of modified RPL3 has had mixed results .
12-1	1436-1446	Transgenic	abstract[80]	new[80]	ana	13-1[0_80]
12-2	1447-1457	expression	abstract[80]	new[80]	_	_
12-3	1458-1460	of	abstract[80]	new[80]	_	_
12-4	1461-1469	modified	abstract[80]|abstract[81]	new[80]|giv[81]	coref	13-10[0_81]
12-5	1470-1474	RPL3	abstract[80]|abstract[81]	new[80]|giv[81]	_	_
12-6	1475-1478	has	_	_	_	_
12-7	1479-1482	had	_	_	_	_
12-8	1483-1488	mixed	abstract[82]	new[82]	_	_
12-9	1489-1496	results	abstract[82]	new[82]	_	_
12-10	1497-1498	.	_	_	_	_

#Text=It was determined that the expression of the tomato RPL3 gene with a modified W-finger ( W258C ) had a minimal effect on the ability of transgenic tobacco to tolerate DON .
13-1	1499-1501	It	abstract	giv	_	_
13-2	1502-1505	was	_	_	_	_
13-3	1506-1516	determined	_	_	_	_
13-4	1517-1521	that	_	_	_	_
13-5	1522-1525	the	abstract[84]	new[84]	_	_
13-6	1526-1536	expression	abstract[84]	new[84]	_	_
13-7	1537-1539	of	abstract[84]	new[84]	_	_
13-8	1540-1543	the	abstract[84]|abstract[85]	new[84]|new[85]	_	_
13-9	1544-1550	tomato	abstract[84]|abstract[85]	new[84]|new[85]	_	_
13-10	1551-1555	RPL3	abstract[84]|abstract|abstract[87]	new[84]|giv|new[87]	coref|coref|coref|coref	14-10[96_0]|17-25[131_87]|14-10[96_0]|17-25[131_87]
13-11	1556-1560	gene	abstract[84]|abstract[87]	new[84]|new[87]	_	_
13-12	1561-1565	with	abstract[84]	new[84]	_	_
13-13	1566-1567	a	abstract[84]|abstract[88]	new[84]|giv[88]	appos	13-17[0_88]
13-14	1568-1576	modified	abstract[84]|abstract[88]	new[84]|giv[88]	_	_
13-15	1577-1585	W-finger	abstract[84]|abstract[88]	new[84]|giv[88]	_	_
13-16	1586-1587	(	_	_	_	_
13-17	1588-1593	W258C	abstract	giv	_	_
13-18	1594-1595	)	_	_	_	_
13-19	1596-1599	had	_	_	_	_
13-20	1600-1601	a	abstract[90]	giv[90]	_	_
13-21	1602-1609	minimal	abstract[90]	giv[90]	_	_
13-22	1610-1616	effect	abstract[90]	giv[90]	_	_
13-23	1617-1619	on	abstract[90]	giv[90]	_	_
13-24	1620-1623	the	abstract[90]|abstract[91]	giv[90]|new[91]	_	_
13-25	1624-1631	ability	abstract[90]|abstract[91]	giv[90]|new[91]	_	_
13-26	1632-1634	of	abstract[90]|abstract[91]	giv[90]|new[91]	_	_
13-27	1635-1645	transgenic	abstract[90]|abstract[91]|substance[92]	giv[90]|new[91]|new[92]	coref	15-18[0_92]
13-28	1646-1653	tobacco	abstract[90]|abstract[91]|substance[92]	giv[90]|new[91]|new[92]	_	_
13-29	1654-1656	to	_	_	_	_
13-30	1657-1665	tolerate	_	_	_	_
13-31	1666-1669	DON	place	giv	coref	14-19
13-32	1670-1671	.	_	_	_	_

#Text=Additionally , transgenic plants were found to preferentially utilize the wild-type RPL3 ( except at sub-lethal concentrations of DON ) and these observations were corroborated using yeast transformants .
14-1	1672-1684	Additionally	_	_	_	_
14-2	1685-1686	,	_	_	_	_
14-3	1687-1697	transgenic	plant[94]	giv[94]	coref	17-31[132_94]
14-4	1698-1704	plants	plant[94]	giv[94]	_	_
14-5	1705-1709	were	_	_	_	_
14-6	1710-1715	found	_	_	_	_
14-7	1716-1718	to	_	_	_	_
14-8	1719-1733	preferentially	_	_	_	_
14-9	1734-1741	utilize	_	_	_	_
14-10	1742-1745	the	abstract[96]	giv[96]	coref	15-9[104_96]
14-11	1746-1755	wild-type	abstract|abstract[96]	new|giv[96]	coref	16-32
14-12	1756-1760	RPL3	abstract[96]	giv[96]	_	_
14-13	1761-1762	(	_	_	_	_
14-14	1763-1769	except	_	_	_	_
14-15	1770-1772	at	_	_	_	_
14-16	1773-1783	sub-lethal	abstract[97]	new[97]	_	_
14-17	1784-1798	concentrations	abstract[97]	new[97]	_	_
14-18	1799-1801	of	abstract[97]	new[97]	_	_
14-19	1802-1805	DON	abstract[97]|quantity	new[97]|giv	coref	15-15
14-20	1806-1807	)	_	_	_	_
14-21	1808-1811	and	_	_	_	_
14-22	1812-1817	these	abstract[99]	new[99]	_	_
14-23	1818-1830	observations	abstract[99]	new[99]	_	_
14-24	1831-1835	were	_	_	_	_
14-25	1836-1848	corroborated	_	_	_	_
14-26	1849-1854	using	_	_	_	_
14-27	1855-1860	yeast	substance|abstract[101]	giv|new[101]	coref|coref	16-17|16-17
14-28	1861-1874	transformants	abstract[101]	new[101]	_	_
14-29	1875-1876	.	_	_	_	_

#Text=On the other hand , transgenic expression of a W258C modified rice RPL3 conferred DON tolerance in tobacco protoplasts , as well as FEB resistance in maize .
15-1	1877-1879	On	_	_	_	_
15-2	1880-1883	the	_	_	_	_
15-3	1884-1889	other	_	_	_	_
15-4	1890-1894	hand	_	_	_	_
15-5	1895-1896	,	_	_	_	_
15-6	1897-1907	transgenic	abstract[102]	new[102]	_	_
15-7	1908-1918	expression	abstract[102]	new[102]	_	_
15-8	1919-1921	of	abstract[102]	new[102]	_	_
15-9	1922-1923	a	abstract[102]|abstract[104]	new[102]|giv[104]	coref	16-13[114_104]
15-10	1924-1929	W258C	abstract[102]|abstract[104]	new[102]|giv[104]	_	_
15-11	1930-1938	modified	abstract[102]|abstract[104]	new[102]|giv[104]	_	_
15-12	1939-1943	rice	abstract[102]|substance|abstract[104]	new[102]|new|giv[104]	_	_
15-13	1944-1948	RPL3	abstract[102]|abstract[104]	new[102]|giv[104]	_	_
15-14	1949-1958	conferred	_	_	_	_
15-15	1959-1962	DON	place|abstract[106]	giv|giv[106]	coref|coref|coref|coref	16-20|18-43[154_106]|16-20|18-43[154_106]
15-16	1963-1972	tolerance	abstract[106]	giv[106]	_	_
15-17	1973-1975	in	abstract[106]	giv[106]	_	_
15-18	1976-1983	tobacco	abstract[106]|substance|object[108]	giv[106]|giv|new[108]	coref|coref	18-26|18-26
15-19	1984-1995	protoplasts	abstract[106]|object[108]	giv[106]|new[108]	_	_
15-20	1996-1997	,	_	_	_	_
15-21	1998-2000	as	_	_	_	_
15-22	2001-2005	well	_	_	_	_
15-23	2006-2008	as	_	_	_	_
15-24	2009-2012	FEB	event|abstract[110]	new|giv[110]	ana|ana	16-1[0_110]|16-1[0_110]
15-25	2013-2023	resistance	abstract[110]	giv[110]	_	_
15-26	2024-2026	in	abstract[110]	giv[110]	_	_
15-27	2027-2032	maize	abstract[110]|plant	giv[110]|new	_	_
15-28	2033-2034	.	_	_	_	_

#Text=It has also been suggested by Di et al. that expression of a truncated RPL3 from yeast could reduce DON toxicity in cereals by drawing the toxin away from the functional wild-type RPL3 .
16-1	2035-2037	It	abstract	giv	coref	20-37[175_0]
16-2	2038-2041	has	_	_	_	_
16-3	2042-2046	also	_	_	_	_
16-4	2047-2051	been	_	_	_	_
16-5	2052-2061	suggested	_	_	_	_
16-6	2062-2064	by	_	_	_	_
16-7	2065-2067	Di	_	_	_	_
16-8	2068-2070	et	_	_	_	_
16-9	2071-2074	al.	_	_	_	_
16-10	2075-2079	that	abstract[113]	new[113]	_	_
16-11	2080-2090	expression	abstract[113]	new[113]	_	_
16-12	2091-2093	of	abstract[113]	new[113]	_	_
16-13	2094-2095	a	abstract[113]|abstract[114]	new[113]|giv[114]	coref	16-30[121_114]
16-14	2096-2105	truncated	abstract[113]|abstract[114]	new[113]|giv[114]	_	_
16-15	2106-2110	RPL3	abstract[113]|abstract[114]	new[113]|giv[114]	_	_
16-16	2111-2115	from	abstract[113]|abstract[114]	new[113]|giv[114]	_	_
16-17	2116-2121	yeast	abstract[113]|abstract[114]|animal	new[113]|giv[114]|giv	coref	17-5
16-18	2122-2127	could	_	_	_	_
16-19	2128-2134	reduce	_	_	_	_
16-20	2135-2138	DON	place|abstract[117]	giv|new[117]	coref|coref	17-42|17-42
16-21	2139-2147	toxicity	abstract[117]	new[117]	_	_
16-22	2148-2150	in	_	_	_	_
16-23	2151-2158	cereals	plant	new	_	_
16-24	2159-2161	by	_	_	_	_
16-25	2162-2169	drawing	_	_	_	_
16-26	2170-2173	the	substance[119]	new[119]	coref	23-28[213_119]
16-27	2174-2179	toxin	substance[119]	new[119]	_	_
16-28	2180-2184	away	_	_	_	_
16-29	2185-2189	from	_	_	_	_
16-30	2190-2193	the	abstract[121]	giv[121]	coref	17-4[124_121]
16-31	2194-2204	functional	abstract[121]	giv[121]	_	_
16-32	2205-2214	wild-type	abstract|abstract[121]	giv|giv[121]	_	_
16-33	2215-2219	RPL3	abstract[121]	giv[121]	_	_
16-34	2220-2221	.	_	_	_	_

#Text=The authors expressed truncated yeast RPL3 ( ΔL3 ) in wheat and found that , in addition to an increase in the expression of the endogenous wheat RPL3 gene , transgenic plants displayed a reduction in FHB symptoms as well as DON accumulation .
17-1	2222-2225	The	person[122]	new[122]	_	_
17-2	2226-2233	authors	person[122]	new[122]	_	_
17-3	2234-2243	expressed	_	_	_	_
17-4	2244-2253	truncated	abstract[124]	giv[124]	appos	17-8[0_124]
17-5	2254-2259	yeast	substance|abstract[124]	giv|giv[124]	_	_
17-6	2260-2264	RPL3	abstract[124]	giv[124]	_	_
17-7	2265-2266	(	_	_	_	_
17-8	2267-2270	ΔL3	abstract	giv	coref	17-28
17-9	2271-2272	)	_	_	_	_
17-10	2273-2275	in	_	_	_	_
17-11	2276-2281	wheat	plant	new	coref	17-26[129_0]
17-12	2282-2285	and	_	_	_	_
17-13	2286-2291	found	_	_	_	_
17-14	2292-2296	that	_	_	_	_
17-15	2297-2298	,	_	_	_	_
17-16	2299-2301	in	_	_	_	_
17-17	2302-2310	addition	_	_	_	_
17-18	2311-2313	to	_	_	_	_
17-19	2314-2316	an	abstract[127]	new[127]	_	_
17-20	2317-2325	increase	abstract[127]	new[127]	_	_
17-21	2326-2328	in	abstract[127]	new[127]	_	_
17-22	2329-2332	the	abstract[127]|abstract[128]	new[127]|new[128]	_	_
17-23	2333-2343	expression	abstract[127]|abstract[128]	new[127]|new[128]	_	_
17-24	2344-2346	of	abstract[127]|abstract[128]	new[127]|new[128]	_	_
17-25	2347-2350	the	abstract[127]|abstract[128]|abstract[131]	new[127]|new[128]|giv[131]	coref	18-35[151_131]
17-26	2351-2361	endogenous	abstract[127]|abstract[128]|plant[129]|abstract[131]	new[127]|new[128]|giv[129]|giv[131]	coref	19-28[0_129]
17-27	2362-2367	wheat	abstract[127]|abstract[128]|plant[129]|abstract[131]	new[127]|new[128]|giv[129]|giv[131]	_	_
17-28	2368-2372	RPL3	abstract[127]|abstract[128]|person|abstract[131]	new[127]|new[128]|giv|giv[131]	coref	18-15[141_0]
17-29	2373-2377	gene	abstract[127]|abstract[128]|abstract[131]	new[127]|new[128]|giv[131]	_	_
17-30	2378-2379	,	_	_	_	_
17-31	2380-2390	transgenic	plant[132]	giv[132]	_	_
17-32	2391-2397	plants	plant[132]	giv[132]	_	_
17-33	2398-2407	displayed	_	_	_	_
17-34	2408-2409	a	abstract[133]	new[133]	_	_
17-35	2410-2419	reduction	abstract[133]	new[133]	_	_
17-36	2420-2422	in	abstract[133]	new[133]	_	_
17-37	2423-2426	FHB	abstract[133]|abstract|abstract[135]	new[133]|new|new[135]	_	_
17-38	2427-2435	symptoms	abstract[133]|abstract[135]	new[133]|new[135]	_	_
17-39	2436-2438	as	_	_	_	_
17-40	2439-2443	well	_	_	_	_
17-41	2444-2446	as	_	_	_	_
17-42	2447-2450	DON	place|abstract[137]	giv|new[137]	coref|coref	18-44|18-44
17-43	2451-2463	accumulation	abstract[137]	new[137]	_	_
17-44	2464-2465	.	_	_	_	_

#Text=In a similar study , the same group had earlier reported that co-expression of ΔL3 together with a Pokeweed Antiviral Protein ( PAP ) in tobacco cells resulted in increased expression of the host RPL3 gene , and this was coincident with improved DON tolerance .
18-1	2466-2468	In	_	_	_	_
18-2	2469-2470	a	abstract[138]	new[138]	coref	20-2[166_138]
18-3	2471-2478	similar	abstract[138]	new[138]	_	_
18-4	2479-2484	study	abstract[138]	new[138]	_	_
18-5	2485-2486	,	_	_	_	_
18-6	2487-2490	the	person[139]	new[139]	_	_
18-7	2491-2495	same	person[139]	new[139]	_	_
18-8	2496-2501	group	person[139]	new[139]	_	_
18-9	2502-2505	had	_	_	_	_
18-10	2506-2513	earlier	_	_	_	_
18-11	2514-2522	reported	_	_	_	_
18-12	2523-2527	that	abstract[140]	new[140]	_	_
18-13	2528-2541	co-expression	abstract[140]	new[140]	_	_
18-14	2542-2544	of	abstract[140]	new[140]	_	_
18-15	2545-2548	ΔL3	abstract[140]|abstract[141]	new[140]|giv[141]	coref	18-35[0_141]
18-16	2549-2557	together	abstract[140]|abstract[141]	new[140]|giv[141]	_	_
18-17	2558-2562	with	abstract[140]|abstract[141]	new[140]|giv[141]	_	_
18-18	2563-2564	a	abstract[140]|abstract[141]|substance[144]	new[140]|giv[141]|giv[144]	_	_
18-19	2565-2573	Pokeweed	abstract[140]|abstract[141]|plant|substance[144]	new[140]|giv[141]|new|giv[144]	_	_
18-20	2574-2583	Antiviral	abstract[140]|abstract[141]|person|substance[144]	new[140]|giv[141]|new|giv[144]	_	_
18-21	2584-2591	Protein	abstract[140]|abstract[141]|substance[144]	new[140]|giv[141]|giv[144]	_	_
18-22	2592-2593	(	_	_	_	_
18-23	2594-2597	PAP	organization	new	_	_
18-24	2598-2599	)	_	_	_	_
18-25	2600-2602	in	_	_	_	_
18-26	2603-2610	tobacco	substance|object[147]	giv|new[147]	_	_
18-27	2611-2616	cells	object[147]	new[147]	_	_
18-28	2617-2625	resulted	_	_	_	_
18-29	2626-2628	in	_	_	_	_
18-30	2629-2638	increased	abstract[148]	new[148]	_	_
18-31	2639-2649	expression	abstract[148]	new[148]	_	_
18-32	2650-2652	of	abstract[148]	new[148]	_	_
18-33	2653-2656	the	abstract[148]|person[149]	new[148]|new[149]	_	_
18-34	2657-2661	host	abstract[148]|person[149]	new[148]|new[149]	_	_
18-35	2662-2666	RPL3	person|abstract[151]	giv|giv[151]	ana|ana	18-39[0_151]|18-39[0_151]
18-36	2667-2671	gene	abstract[151]	giv[151]	_	_
18-37	2672-2673	,	_	_	_	_
18-38	2674-2677	and	_	_	_	_
18-39	2678-2682	this	abstract	giv	coref	22-12
18-40	2683-2686	was	_	_	_	_
18-41	2687-2697	coincident	_	_	_	_
18-42	2698-2702	with	_	_	_	_
18-43	2703-2711	improved	abstract[154]	giv[154]	_	_
18-44	2712-2715	DON	place|abstract[154]	giv|giv[154]	coref	19-25
18-45	2716-2725	tolerance	abstract[154]	giv[154]	_	_
18-46	2726-2727	.	_	_	_	_

#Text=In this context , it is interesting that the up-regulation of different components of the ribosome has been observed directly in response to exogenous DON applications in wheat .
19-1	2728-2730	In	_	_	_	_
19-2	2731-2735	this	abstract[155]	new[155]	_	_
19-3	2736-2743	context	abstract[155]	new[155]	_	_
19-4	2744-2745	,	_	_	_	_
19-5	2746-2748	it	place	new	cata	19-5[0_160]
19-6	2749-2751	is	_	_	_	_
19-7	2752-2763	interesting	_	_	_	_
19-8	2764-2768	that	place[160]	new[160]	_	_
19-9	2769-2772	the	abstract[157]|place[160]	new[157]|new[160]	coref	21-7[177_157]
19-10	2773-2786	up-regulation	abstract[157]|place[160]	new[157]|new[160]	_	_
19-11	2787-2789	of	abstract[157]|place[160]	new[157]|new[160]	_	_
19-12	2790-2799	different	abstract[157]|abstract[158]|place[160]	new[157]|new[158]|new[160]	coref	20-15[170_158]
19-13	2800-2810	components	abstract[157]|abstract[158]|place[160]	new[157]|new[158]|new[160]	_	_
19-14	2811-2813	of	abstract[157]|abstract[158]|place[160]	new[157]|new[158]|new[160]	_	_
19-15	2814-2817	the	abstract[157]|abstract[158]|object[159]|place[160]	new[157]|new[158]|giv[159]|new[160]	coref	22-34[0_159]
19-16	2818-2826	ribosome	abstract[157]|abstract[158]|object[159]|place[160]	new[157]|new[158]|giv[159]|new[160]	_	_
19-17	2827-2830	has	place[160]	new[160]	_	_
19-18	2831-2835	been	place[160]	new[160]	_	_
19-19	2836-2844	observed	place[160]	new[160]	_	_
19-20	2845-2853	directly	place[160]	new[160]	_	_
19-21	2854-2856	in	_	_	_	_
19-22	2857-2865	response	abstract[161]	new[161]	_	_
19-23	2866-2868	to	abstract[161]	new[161]	_	_
19-24	2869-2878	exogenous	abstract[161]|abstract[163]	new[161]|new[163]	_	_
19-25	2879-2882	DON	abstract[161]|place|abstract[163]	new[161]|giv|new[163]	coref	20-10
19-26	2883-2895	applications	abstract[161]|abstract[163]	new[161]|new[163]	_	_
19-27	2896-2898	in	abstract[161]|abstract[163]	new[161]|new[163]	_	_
19-28	2899-2904	wheat	abstract[161]|abstract[163]|plant	new[161]|new[163]|giv	_	_
19-29	2905-2906	.	_	_	_	_

#Text=In a transcriptomics study by Foroud et al. , DON induced higher expression of ribosomal components , but only in the resistant genotypes , which incidentally were generated through a process that provides selection pressure for trichothecene resistance .
20-1	2907-2909	In	_	_	_	_
20-2	2910-2911	a	abstract[166]	giv[166]	_	_
20-3	2912-2927	transcriptomics	abstract|abstract[166]	new|giv[166]	_	_
20-4	2928-2933	study	abstract[166]	giv[166]	_	_
20-5	2934-2936	by	abstract[166]	giv[166]	_	_
20-6	2937-2943	Foroud	abstract[166]|person	giv[166]|new	_	_
20-7	2944-2946	et	abstract[166]	giv[166]	_	_
20-8	2947-2950	al.	abstract[166]	giv[166]	_	_
20-9	2951-2952	,	_	_	_	_
20-10	2953-2956	DON	place	giv	_	_
20-11	2957-2964	induced	_	_	_	_
20-12	2965-2971	higher	abstract[169]	new[169]	coref	21-33[0_169]
20-13	2972-2982	expression	abstract[169]	new[169]	_	_
20-14	2983-2985	of	abstract[169]	new[169]	_	_
20-15	2986-2995	ribosomal	abstract[169]|abstract[170]	new[169]|giv[170]	_	_
20-16	2996-3006	components	abstract[169]|abstract[170]	new[169]|giv[170]	_	_
20-17	3007-3008	,	_	_	_	_
20-18	3009-3012	but	_	_	_	_
20-19	3013-3017	only	abstract[171]	new[171]	coref	21-38[187_171]
20-20	3018-3020	in	abstract[171]	new[171]	_	_
20-21	3021-3024	the	abstract[171]	new[171]	_	_
20-22	3025-3034	resistant	abstract[171]	new[171]	_	_
20-23	3035-3044	genotypes	abstract[171]	new[171]	_	_
20-24	3045-3046	,	_	_	_	_
20-25	3047-3052	which	_	_	_	_
20-26	3053-3065	incidentally	_	_	_	_
20-27	3066-3070	were	_	_	_	_
20-28	3071-3080	generated	_	_	_	_
20-29	3081-3088	through	_	_	_	_
20-30	3089-3090	a	abstract[172]	new[172]	_	_
20-31	3091-3098	process	abstract[172]	new[172]	_	_
20-32	3099-3103	that	_	_	_	_
20-33	3104-3112	provides	_	_	_	_
20-34	3113-3122	selection	abstract|abstract[174]	new|new[174]	_	_
20-35	3123-3131	pressure	abstract[174]	new[174]	_	_
20-36	3132-3135	for	abstract[174]	new[174]	_	_
20-37	3136-3149	trichothecene	abstract[174]|abstract[175]	new[174]|giv[175]	coref	21-36[186_175]
20-38	3150-3160	resistance	abstract[174]|abstract[175]	new[174]|giv[175]	_	_
20-39	3161-3162	.	_	_	_	_

#Text=There are many potential explanations for this up-regulation , though at this stage only speculation can be offered , and it is also unknown whether there is a direct link with this expression pattern and resistance in these genotypes .
21-1	3163-3168	There	_	_	_	_
21-2	3169-3172	are	_	_	_	_
21-3	3173-3177	many	abstract[176]	new[176]	_	_
21-4	3178-3187	potential	abstract[176]	new[176]	_	_
21-5	3188-3200	explanations	abstract[176]	new[176]	_	_
21-6	3201-3204	for	abstract[176]	new[176]	_	_
21-7	3205-3209	this	abstract[176]|abstract[177]	new[176]|giv[177]	_	_
21-8	3210-3223	up-regulation	abstract[176]|abstract[177]	new[176]|giv[177]	_	_
21-9	3224-3225	,	_	_	_	_
21-10	3226-3232	though	abstract[180]	new[180]	_	_
21-11	3233-3235	at	abstract[180]	new[180]	_	_
21-12	3236-3240	this	abstract[178]|abstract[180]	new[178]|new[180]	_	_
21-13	3241-3246	stage	abstract[178]|abstract[180]	new[178]|new[180]	_	_
21-14	3247-3251	only	abstract[179]|abstract[180]	new[179]|new[180]	_	_
21-15	3252-3263	speculation	abstract[179]|abstract[180]	new[179]|new[180]	_	_
21-16	3264-3267	can	abstract[180]	new[180]	_	_
21-17	3268-3270	be	abstract[180]	new[180]	_	_
21-18	3271-3278	offered	abstract[180]	new[180]	_	_
21-19	3279-3280	,	_	_	_	_
21-20	3281-3284	and	_	_	_	_
21-21	3285-3287	it	abstract	new	cata	21-21[0_182]
21-22	3288-3290	is	_	_	_	_
21-23	3291-3295	also	_	_	_	_
21-24	3296-3303	unknown	_	_	_	_
21-25	3304-3311	whether	abstract[182]	new[182]	_	_
21-26	3312-3317	there	abstract[182]	new[182]	_	_
21-27	3318-3320	is	abstract[182]	new[182]	_	_
21-28	3321-3322	a	abstract[183]	new[183]	_	_
21-29	3323-3329	direct	abstract[183]	new[183]	_	_
21-30	3330-3334	link	abstract[183]	new[183]	_	_
21-31	3335-3339	with	abstract[183]	new[183]	_	_
21-32	3340-3344	this	abstract[183]|abstract[185]	new[183]|new[185]	_	_
21-33	3345-3355	expression	abstract[183]|abstract|abstract[185]	new[183]|giv|new[185]	coref	22-11[191_0]
21-34	3356-3363	pattern	abstract[183]|abstract[185]	new[183]|new[185]	_	_
21-35	3364-3367	and	abstract[183]	new[183]	_	_
21-36	3368-3378	resistance	abstract[183]|abstract[186]	new[183]|giv[186]	ana	22-1[0_186]
21-37	3379-3381	in	abstract[183]|abstract[186]	new[183]|giv[186]	_	_
21-38	3382-3387	these	abstract[183]|abstract[186]|abstract[187]	new[183]|giv[186]|giv[187]	_	_
21-39	3388-3397	genotypes	abstract[183]|abstract[186]|abstract[187]	new[183]|giv[186]|giv[187]	_	_
21-40	3398-3399	.	_	_	_	_

#Text=It should be noted , however , that changes in ribosomal gene expression have been reported in different plant-pathogen interactions ( e. g. , ) , and importantly , according to the ‘ ribosome filter hypothesis ’ alterations in ribosomal composition or specialized ribosomes are thought to bias incorporation of specific mRNAs to translation .
22-1	3400-3402	It	abstract	giv	coref	23-25[212_0]
22-2	3403-3409	should	_	_	_	_
22-3	3410-3412	be	_	_	_	_
22-4	3413-3418	noted	_	_	_	_
22-5	3419-3420	,	_	_	_	_
22-6	3421-3428	however	_	_	_	_
22-7	3429-3430	,	_	_	_	_
22-8	3431-3435	that	abstract[189]	new[189]	coref	23-10[207_189]
22-9	3436-3443	changes	abstract[189]	new[189]	_	_
22-10	3444-3446	in	abstract[189]	new[189]	_	_
22-11	3447-3456	ribosomal	abstract[189]|abstract[191]	new[189]|giv[191]	coref	23-15[210_191]
22-12	3457-3461	gene	abstract[189]|abstract|abstract[191]	new[189]|giv|giv[191]	coref	23-16
22-13	3462-3472	expression	abstract[189]|abstract[191]	new[189]|giv[191]	_	_
22-14	3473-3477	have	_	_	_	_
22-15	3478-3482	been	_	_	_	_
22-16	3483-3491	reported	_	_	_	_
22-17	3492-3494	in	_	_	_	_
22-18	3495-3504	different	abstract[192]	new[192]	_	_
22-19	3505-3519	plant-pathogen	abstract[192]	new[192]	_	_
22-20	3520-3532	interactions	abstract[192]	new[192]	_	_
22-21	3533-3534	(	_	_	_	_
22-22	3535-3537	e.	_	_	_	_
22-23	3538-3540	g.	abstract	new	_	_
22-24	3541-3542	,	_	_	_	_
22-25	3543-3544	)	_	_	_	_
22-26	3545-3546	,	_	_	_	_
22-27	3547-3550	and	_	_	_	_
22-28	3551-3562	importantly	_	_	_	_
22-29	3563-3564	,	_	_	_	_
22-30	3565-3574	according	_	_	_	_
22-31	3575-3577	to	_	_	_	_
22-32	3578-3581	the	abstract[197]	new[197]	_	_
22-33	3582-3583	‘	abstract[196]|abstract[197]	new[196]|new[197]	coref	23-3[205_196]
22-34	3584-3592	ribosome	object|abstract[196]|abstract[197]	giv|new[196]|new[197]	_	_
22-35	3593-3599	filter	object|abstract[196]|abstract[197]	new|new[196]|new[197]	coref	23-4
22-36	3600-3610	hypothesis	abstract[196]|abstract[197]	new[196]|new[197]	_	_
22-37	3611-3612	’	abstract[196]|abstract[197]	new[196]|new[197]	_	_
22-38	3613-3624	alterations	abstract[197]	new[197]	_	_
22-39	3625-3627	in	abstract[197]	new[197]	_	_
22-40	3628-3637	ribosomal	abstract[197]|animal|abstract[199]	new[197]|new|new[199]	coref|coref	23-15|23-15
22-41	3638-3649	composition	abstract[197]|abstract[199]	new[197]|new[199]	_	_
22-42	3650-3652	or	abstract[197]	new[197]	_	_
22-43	3653-3664	specialized	abstract[197]|object[200]	new[197]|giv[200]	_	_
22-44	3665-3674	ribosomes	abstract[197]|object[200]	new[197]|giv[200]	_	_
22-45	3675-3678	are	_	_	_	_
22-46	3679-3686	thought	_	_	_	_
22-47	3687-3689	to	_	_	_	_
22-48	3690-3694	bias	_	_	_	_
22-49	3695-3708	incorporation	event[201]	new[201]	_	_
22-50	3709-3711	of	event[201]	new[201]	_	_
22-51	3712-3720	specific	event[201]|abstract[202]	new[201]|new[202]	_	_
22-52	3721-3726	mRNAs	event[201]|abstract[202]	new[201]|new[202]	_	_
22-53	3727-3729	to	event[201]|abstract[202]	new[201]|new[202]	_	_
22-54	3730-3741	translation	event[201]|abstract[202]|abstract	new[201]|new[202]|giv	coref	23-20[211_0]
22-55	3742-3743	.	_	_	_	_

#Text=Thus , the filter hypothesis offers the possibility that the reported DON-induced changes in ribosomal gene expression might coordinate defense-related translation rather than conferring ribosomal resistance to the toxin .
23-1	3744-3748	Thus	_	_	_	_
23-2	3749-3750	,	_	_	_	_
23-3	3751-3754	the	abstract[205]	giv[205]	_	_
23-4	3755-3761	filter	object|abstract[205]	giv|giv[205]	_	_
23-5	3762-3772	hypothesis	abstract[205]	giv[205]	_	_
23-6	3773-3779	offers	_	_	_	_
23-7	3780-3783	the	abstract[206]	new[206]	_	_
23-8	3784-3795	possibility	abstract[206]	new[206]	_	_
23-9	3796-3800	that	abstract[206]	new[206]	_	_
23-10	3801-3804	the	abstract[206]|abstract[207]	new[206]|giv[207]	_	_
23-11	3805-3813	reported	abstract[206]|abstract[207]	new[206]|giv[207]	_	_
23-12	3814-3825	DON-induced	abstract[206]|abstract[207]	new[206]|giv[207]	_	_
23-13	3826-3833	changes	abstract[206]|abstract[207]	new[206]|giv[207]	_	_
23-14	3834-3836	in	abstract[206]|abstract[207]	new[206]|giv[207]	_	_
23-15	3837-3846	ribosomal	abstract[206]|abstract[207]|person|abstract[210]	new[206]|giv[207]|giv|giv[210]	_	_
23-16	3847-3851	gene	abstract[206]|abstract[207]|abstract|abstract[210]	new[206]|giv[207]|giv|giv[210]	_	_
23-17	3852-3862	expression	abstract[206]|abstract[207]|abstract[210]	new[206]|giv[207]|giv[210]	_	_
23-18	3863-3868	might	abstract[206]	new[206]	_	_
23-19	3869-3879	coordinate	abstract[206]	new[206]	_	_
23-20	3880-3895	defense-related	abstract[206]|abstract[211]	new[206]|giv[211]	_	_
23-21	3896-3907	translation	abstract[206]|abstract[211]	new[206]|giv[211]	_	_
23-22	3908-3914	rather	_	_	_	_
23-23	3915-3919	than	_	_	_	_
23-24	3920-3930	conferring	_	_	_	_
23-25	3931-3940	ribosomal	abstract[212]	giv[212]	_	_
23-26	3941-3951	resistance	abstract[212]	giv[212]	_	_
23-27	3952-3954	to	abstract[212]	giv[212]	_	_
23-28	3955-3958	the	abstract[212]|substance[213]	giv[212]|giv[213]	_	_
23-29	3959-3964	toxin	abstract[212]|substance[213]	giv[212]|giv[213]	_	_
23-30	3965-3966	.	_	_	_	_
